Market Cap
Arena
Rankings
▼
Calendar
Sectors
▼
LLY (Eli Lilly and Company) Stock Financials & Earnings | Market Cap Arena
2025 Q4
LLY
Eli Lilly and Company
Mkt Cap
$951B
LLY
Eli Lilly and Company
$951B
2025 Q4
Company Info & Key Metrics
Healthcare
Drug Manufacturers - General
Country
🇺🇸 United States
Exchange
NYSE
Revenue
$19.3B
YoY Growth
+42.6%
QoQ Growth
+9.6%
Net Income
$6.6B
EPS
$7.39
Free Cash Flow
$678M
Gross Margin
85.1%
Op. Margin
45.5%
Net Margin
34.4%
FCF Margin
3.5%
Rev Multiple (TTM)
14.6x
P/E Ratio (TTM)
46.1x
Revenue & Profitability
Revenue
Gross Profit
Operating Income
Quarter
Revenue
Gross Profit
Op. Income
Q1 23
$7.0B
$5.3B
$1.7B
Q2 23
$8.3B
$6.5B
$2.3B
Q3 23
$9.5B
$7.6B
$3.5B
Q4 23
$9.4B
$7.6B
$3.2B
Q1 24
$8.8B
$7.1B
$2.7B
Q2 24
$11.3B
$9.1B
$4.4B
Q3 24
$11.4B
$9.3B
$4.5B
Q4 24
$13.5B
$11.1B
$5.8B
Q1 25
$12.7B
$10.5B
$5.4B
Q2 25
$15.6B
$13.1B
$7.1B
Q3 25
$17.6B
$14.6B
$8.4B
Q4 25
$19.3B
$16.4B
$8.8B
marketcaparena.com
Revenue Breakdown
LLY
Eli Lilly and Company
Revenue Breakdown
Q4 2025
marketcaparena.com
Valuation
P/S Ratio
P/E Ratio
Quarter
P/S
P/E
Q1 23
34.4x
167.3x
Q2 23
32.2x
146.4x
Q3 23
29.7x
190.7x
Q4 23
27.9x
181.5x
Q1 24
26.5x
155.0x
Q2 24
24.4x
129.6x
Q3 24
23.3x
113.7x
Q4 24
21.1x
89.8x
Q1 25
19.4x
85.7x
Q2 25
17.9x
68.9x
Q3 25
16.0x
51.7x
Q4 25
14.6x
46.1x
marketcaparena.com
Operating Cash Flow
Operating Cash Flow
Free Cash Flow
Quarter
Operating CF
Free CF
Q1 23
$1.7B
$827M
Q2 23
$632M
-$204M
Q3 23
$2.2B
-$1.8B
Q4 23
-$312M
-$2.0B
Q1 24
$1.2B
$180M
Q2 24
$1.5B
$63M
Q3 24
$3.7B
-$459M
Q4 24
$2.5B
$727M
Q1 25
$1.7B
-$1.6B
Q2 25
$3.1B
$1.3B
Q3 25
$8.8B
$8.6B
Q4 25
$3.2B
$678M
marketcaparena.com
Capital Expenditures
CapEx
Quarter
CapEx
Q1 23
$904M
Q2 23
$836M
Q3 23
$4.0B
Q4 23
$1.7B
Q1 24
$986M
Q2 24
$1.4B
Q3 24
$4.2B
Q4 24
$1.7B
Q1 25
$3.3B
Q2 25
$1.8B
Q3 25
$224M
Q4 25
$2.5B
marketcaparena.com
OpEx vs Revenue Growth (YoY)
Revenue Growth
OpEx Growth
Quarter
Revenue Growth
OpEx Growth
Q1 23
-10.9%
+1.9%
Q2 23
+28.1%
+25.9%
Q3 23
+36.8%
+21.5%
Q4 23
+28.1%
+20.9%
Q1 24
+26.0%
+15.0%
Q2 24
+36.0%
+15.2%
Q3 24
+20.4%
+15.6%
Q4 24
+44.7%
+25.6%
Q1 25
+45.2%
+21.3%
Q2 25
+37.6%
+22.5%
Q3 25
+53.9%
+33.8%
Q4 25
+42.6%
+36.0%
marketcaparena.com
Stock-Based Compensation
SBC ($)
% of Revenue
Quarter
SBC ($)
% of Revenue
Q1 23
$131M
1.9%
Q2 23
$162M
1.9%
Q3 23
$216M
2.3%
Q4 23
$120M
1.3%
Q1 24
$159M
1.8%
Q2 24
$211M
1.9%
Q3 24
$133M
1.2%
Q4 24
$142M
1.0%
Q1 25
$154M
1.2%
Q2 25
$185M
1.2%
Q3 25
$151M
0.9%
Q4 25
$136M
0.7%
marketcaparena.com
OpEx Breakdown
R&D
G&A
Quarter
R&D
G&A
Q1 23
$2.0B
$1.6B
Q2 23
$2.4B
$1.8B
Q3 23
$2.4B
$1.7B
Q4 23
$2.6B
$1.8B
Q1 24
$2.5B
$1.8B
Q2 24
$2.7B
$2.0B
Q3 24
$2.7B
$2.0B
Q4 24
$3.0B
$2.3B
Q1 25
$2.7B
$2.4B
Q2 25
$3.3B
$2.6B
Q3 25
$3.5B
$2.7B
Q4 25
$3.8B
$3.3B
marketcaparena.com
Revenue Segments
Diabetes
Immunology
Neuroscience
Oncology
Other Product, Total
Cardiometabolic Health
Quarter
Diabetes
Immunology
Neuroscience
Oncology
Other Product, Total
Cardiometabolic Health
Q1 23
$4.2B
$778M
$361M
$1.4B
$275M
—
Q2 23
$5.0B
$929M
$387M
$1.7B
$315M
—
Q3 23
$4.7B
$987M
$1.8B
$1.7B
$276M
—
Q1 24
$5.5B
$834M
$553M
$2.1B
$242M
—
Q2 24
—
$1.1B
$487M
$2.5B
$208M
$7.5B
Q3 24
—
$1.2B
$469M
$2.6B
$263M
$7.4B
Q1 25
—
$1.1B
$272M
$1.9B
$213M
$9.2B
Q2 25
—
$1.3B
$344M
$2.4B
$202M
$11.3B
Q3 25
—
$1.4B
$316M
$2.4B
$337M
$13.2B
marketcaparena.com
Revenue by Geography
China
Europe
Japan
Non-US
United States
Quarter
China
Europe
Japan
Non-US
United States
Q1 23
$373M
$1.1B
$387M
$673M
$4.4B
Q2 23
$399M
$1.2B
$456M
$749M
$5.5B
Q3 23
$391M
$2.6B
$391M
$780M
$5.4B
Q4 23
$377M
$1.3B
$439M
$744M
$6.5B
Q1 24
$376M
$1.4B
$364M
$893M
$5.7B
Q2 24
$395M
$1.4B
$463M
$1.2B
$7.8B
Q3 24
$460M
$1.6B
$429M
$1.1B
$7.8B
Q4 24
$429M
$2.4B
$559M
$1.1B
$9.0B
Q1 25
$451M
$2.4B
$402M
$997M
$8.5B
Q2 25
$466M
$2.6B
$521M
$1.2B
$10.8B
Q3 25
$560M
$3.5B
$555M
$1.7B
$11.3B
Q4 25
$474M
$3.1B
$654M
$2.2B
$12.9B
marketcaparena.com
War Chest
Cash & Equivalents
Short-Term Investments
Quarter
Cash
Short-term Investments
Total
Q1 23
$3.5B
$123M
$3.7B
Q2 23
$2.7B
$135M
$2.8B
Q3 23
$2.4B
$113M
$2.5B
Q4 23
$2.8B
$109M
$2.9B
Q1 24
$2.5B
$126M
$2.6B
Q2 24
$3.2B
$140M
$3.4B
Q3 24
$3.4B
$149M
$3.5B
Q4 24
$3.3B
$155M
$3.4B
Q1 25
$3.1B
$127M
$3.2B
Q2 25
$3.4B
$170M
$3.5B
Q3 25
$9.8B
$122M
$9.9B
Q4 25
$7.2B
$105M
$7.3B
marketcaparena.com
Shares Outstanding
Shares Outstanding
Quarter
Shares (Diluted)
QoQ Change
Q1 23
949M
-0.1%
Q2 23
949M
+0.0%
Q3 23
949M
+0.0%
Q4 23
904M
-4.8%
Q1 24
904M
-0.0%
Q2 24
904M
+0.0%
Q3 24
905M
+0.1%
Q4 24
903M
-0.2%
Q1 25
901M
-0.3%
Q2 25
900M
-0.1%
Q3 25
899M
-0.1%
Q4 25
898M
-0.1%
marketcaparena.com
Revenue Per Employee
Revenue / Employee
Year
Revenue/Employee
Employees
FY 14
$501K
39K
FY 15
$484K
41K
FY 16
$506K
42K
FY 17
$491K
41K
FY 18
$556K
39K
FY 19
$664K
34K
FY 20
$701K
35K
FY 21
$809K
35K
FY 22
$732K
39K
FY 23
$794K
43K
FY 24
$958K
47K
FY 25
$326K
200K
marketcaparena.com